Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Researchers conducted a target trial emulation using Danish healthcare data to compare the effectiveness of empagliflozin and dapagliflozin in improving kidney outcomes among patients with T2D. They ...

In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...

A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by lowering blood sugar, but by triggering a molecular shift that dampens ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

Bariatric surgery was shown to protect kidney function and reduce the risk of kidney failure in study participants when compared to GLP-1 medications Friday, September 20, 2024, CLEVELAND: A Cleveland ...